摘要
纳米中药(nano TCM)是指具有生物活性的成分、药用材料或复方,并由纳米技术处理成约100纳米的大小。纳米中药是中药现代化的产物,并应用于中医领域中。本文回顾了近15年来国内外有关纳米中药研究的文献。不同的纳米技术被用于研究不同目标的纳米中药制备技术。机械粉碎技术是中医复方纳米化材料的主要方法,以及纳米药物输送系统是在中药活性成分或活性部位的纳米化的主要途径。以纳米中药为例,提高中药的生物利用度,减少中药的副作用,实现缓释,达到靶向给药,提高药理作用,改善中药给药途径。然而,对于纳米中药研究仍有许多问题需要解决。纳米技术的主要挑战包括:中药现代化理论体系、制备工艺、安全性和稳定性等。
关键词: 乳液,脂质体,纳米颗粒,纳米中药,中药。
图形摘要
Current Drug Targets
Title:Nano Traditional Chinese Medicine: Current Progresses and Future Challenges
Volume: 16 Issue: 13
Author(s): Yi Huang, Yinglan Zhao, Fang Liu and Songqing Liu
Affiliation:
关键词: 乳液,脂质体,纳米颗粒,纳米中药,中药。
摘要: Nano traditional Chinese medicine (nano TCM) refers to bioactive ingredients, bioactive parts, medicinal materials or complex prescription, being approximately 100 nm in size, which are processed by nanotechnology. Nano TCM is a product of the TCM modernization, and is an application of nanotechnology in the field of TCM. This article reviews literatures on researches of nano TCM, which were published in the past 15 years. Different nanotechnologies have been used in preparation of Nano TCM in view of the varying aims of the study. The mechanical crushing technology is the main approach for nanolization of TCM material and complex prescription, and nanoparticulate drug delivery systems is the main approach for nanolization of bioactive ingredients or bioactive parts in TCM. Nano TCM has a number of advantages, for example, enhancing the bioavailability of TCM, reducing the adverse effects of TCM, achieving sustained release, attaining targeted delivery, enhancing pharmacological effects and improving the administration route of TCM. However, there are still many problems that must be resolved in nano TCM research. The main challenges to nano TCM include the theory system of TCM modernization, preparation technology, safety and stability, etc.
Export Options
About this article
Cite this article as:
Yi Huang, Yinglan Zhao, Fang Liu and Songqing Liu , Nano Traditional Chinese Medicine: Current Progresses and Future Challenges, Current Drug Targets 2015; 16 (13) . https://dx.doi.org/10.2174/1389450116666150309122334
DOI https://dx.doi.org/10.2174/1389450116666150309122334 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Distinguished Photons: A Review of In Vivo Spectral Fluorescence Imaging in Small Animals
Current Pharmaceutical Biotechnology Exploring Cytotoxic and Atioxidant Properties of <i>Heliotropium calcareum</i> in Polar and Non-Polar Extracts
Current Nutraceuticals Evolving Treatment Paradigms for HPV-Related Oropharynx Cancer
Current Cancer Therapy Reviews Highlights in Peptide Nanoparticle Carriers Intended to Oral Diseases
Current Topics in Medicinal Chemistry Drug-Targeting Strategies for Prostate Cancer
Current Pharmaceutical Design Recent Developments on 1,2,4-Triazole Nucleus in Anticancer Compounds: A Review
Anti-Cancer Agents in Medicinal Chemistry Hepatocyte FRS2α is Essential for the Endocrine Fibroblast Growth Factor to Limit the Amplitude of Bile Acid Production Induced by Prandial Activity
Current Molecular Medicine Nucleo-Cytoplasmic Transport of Proteins as a Target for Therapeutic Drugs
Current Medicinal Chemistry Flavonoids in Cancer Prevention
Anti-Cancer Agents in Medicinal Chemistry Molecular Targeted Therapies in the Management of Head and Neck Squamous Cell Carcinoma: Recent Developments and Perspectives
Anti-Cancer Agents in Medicinal Chemistry A Synopsis on the Role of Human Papilloma Virus Infection in Cervical Cancer
Current Drug Metabolism Valproic Acid in the Complex Therapy of Malignant Tumors
Current Drug Targets Cell Cycle Regulatory Protein 5 (Cdk5) is a Novel Downstream Target of ERK in Carboplatin Induced Death of Breast Cancer Cells (Supplementary Data)
Current Cancer Drug Targets Opioids and Cannabinoids Interactions: Involvement in Pain Management
Current Drug Targets Receptor Mediated Tumor Targeting: An Emerging Approach for Cancer Therapy
Current Drug Delivery Structural Activity Relationship and Importance of Benzothiazole Derivatives in Medicinal Chemistry: A Comprehensive Review
Mini-Reviews in Organic Chemistry Preparation and Primary Bioevaluation of 99mTc-labeled-1-thio-β-D-Glucose as Melanoma Targeting Agent
Current Radiopharmaceuticals Tubulin Inhibitors: A Patent Survey
Recent Patents on Anti-Cancer Drug Discovery Involvement of Cysteine Proteases in Cancer
Current Medicinal Chemistry The PAX8 / PPARγ Fusion Oncogene as a Potential Therapeutic Target in Follicular Thyroid Carcinoma
Current Drug Targets - Immune, Endocrine & Metabolic Disorders